GlassScriptPhysician profile
Ryan B Moody
NPI 1629191853
$50,381.75
in general payments reported to CMS, 2019-2025
51 companies · $20K in 2025
The $20K reported for 2025 was more than what 95% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,423 · 2020: $1,336 · 2021: $1,222 · 2022: $2,715 · 2023: $12K · 2024: $11K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Food and Beverage: $12K · Consulting Fee: $6,324 · Travel and Lodging: $1,908 · Education: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,310.00 |
| Food and Beverage | $11,788.20 |
| Consulting Fee | $6,324.00 |
| Travel and Lodging | $1,908.02 |
| Education | $356.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $24,971.69 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Genzyme Corporation | $9,115.86 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,120.07 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $2,108.09 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Actelion Pharmaceuticals US, INC. | $1,759.65 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $1,592.61 | 2019-2025 | Dupixent |
| Insmed, INC. | $1,034.34 | 2019-2025 | Arikayce, Brinsupri |
| United Therapeutics Corporation | $881.22 | 2019-2025 | Tyvaso, Tyvaso |
| Merck Sharp & Dohme LLC | $769.17 | 2019-2025 | Winrevair, Zerbaxa, Keytruda |
| Axsome Therapeutics, INC. | $696.22 | 2022-2025 | Sunosi |
| Amgen INC. | $511.52 | 2022-2025 | Tezspire |
| Inspire Medical Systems, INC. | $466.89 | 2019-2025 | Inspire |
| Harmony Biosciences LLC | $436.93 | 2020-2024 | Wakix |
| Mallinckrodt Hospital Products INC. | $399.74 | 2020-2025 | Acthar |
| Jazz Pharmaceuticals INC. | $353.07 | 2019-2024 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $343.23 | 2021-2025 | Prolastin-C Liquid |
| Electromed, INC. | $259.94 | 2019-2024 | Smartvest |
| Mylan Specialty L.P. | $250.75 | 2019-2024 | Yupelri |
| Verona Pharma, INC. | $172.08 | 2025 | Ohtuvayre |
| Genentech USA, INC. | $170.41 | 2019-2020 | |
| Pulmonx Corporation | $158.02 | 2024-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Novartis Pharmaceuticals Corporation | $147.41 | 2020-2023 | |
| Sanofi-Aventis U.S. LLC | $146.98 | 2024-2025 | |
| Sunovion Pharmaceuticals INC. | $122.23 | 2019-2020 | |
| Avadel Cns Pharmaceuticals, LLC | $119.67 | 2024-2025 | Lumryz |
| Takeda Pharmaceuticals U.S.A., INC. | $114.56 | 2021-2025 | Glassia |
| Bayer Healthcare Pharmaceuticals INC. | $96.92 | 2020-2025 | |
| Fisher & Paykel Healthcare INC | $94.45 | 2020-2024 | Fisher & Paykel Healthcare |
| Baxter Healthcare | $94.45 | 2022-2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Inari Medical, INC. | $85.69 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Viatris Specialty LLC | $82.39 | 2025 | Yupelri |
| Circassia INC. | $81.18 | 2019 | |
| Alexion Pharmaceuticals, INC. | $73.62 | 2021-2022 | |
| Pfizer INC. | $60.44 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $55.07 | 2019-2021 | |
| Shionogi INC | $52.67 | 2022-2023 | Fetroja |
| Idorsia Pharmaceuticals US INC | $47.05 | 2023 | Quviviq |
| Eisai INC. | $45.13 | 2020-2021 | |
| Stryker Corporation | $34.98 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $31.19 | 2024 | Impella |
| Inogen, INC. | $29.64 | 2023 | Inogen |
| Teva Pharmaceuticals USA, INC. | $27.57 | 2020 | |
| Mallinckrodt Enterprises LLC | $25.10 | 2019 | |
| Ani Pharmaceuticals, INC. | $24.55 | 2023 | Purified Cortrophin Gel |
| Lilly USA, LLC | $23.18 | 2025 | Zepbound |
| Astellas Pharma US INC | $23.03 | 2023 | Cresemba |
| Pharming Healthcare, INC. | $18.06 | 2022 | |
| Vifor Pharma, INC. | $17.39 | 2024 | Zemaira |
| Avanir Pharmaceuticals, INC. | $14.92 | 2019 | |
| Allergan, INC. | $11.14 | 2020 | |
| Biomerieux INC | $9.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Moody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.